Morrell Martha

SEC source: 0001415889-25-005571 · form4-02252025_110243.xml · derivative · entry 35

Morrell Martha · CIK 0001855616 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 180,449

Underlying: Common Stock · 40,000 shares

Expires 2030-11-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: 1/48th of the shares subject to the option vest in equal monthly installments commencing February 1, 2017.

SEC source: 0001415889-25-005571 · form4-02252025_110243.xml · derivative · entry 34

Morrell Martha · CIK 0001855616 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,234

Underlying: Common Stock · 12,234 shares

Expires 2030-11-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: 1/48th of the shares subject to the option vest in equal monthly installments commencing February 1, 2017.

SEC source: 0001415889-25-005571 · form4-02252025_110243.xml · derivative · entry 33

Morrell Martha · CIK 0001855616 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 192

Underlying: Common Stock · 192 shares

Expires 2030-11-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: 25% of the shares subject to the option vest on July 1, 2012; 1/48th of the shares subject to the option vest in 36 equal monthly installments thereafter.

SEC source: 0001415889-25-005571 · form4-02252025_110243.xml · derivative · entry 32

Morrell Martha · CIK 0001855616 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 192 shares

Expires 2030-11-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: 25% of the shares subject to the option vest on July 1, 2013; 1/48th of the shares subject to the option vest in 36 equal monthly installments thereafter.

SEC source: 0001415889-25-005571 · form4-02252025_110243.xml · derivative · entry 31

Morrell Martha · CIK 0001855616 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 192 shares

Expires 2030-11-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: 25% of the shares subject to the option vest on July 1, 2015; 1/48th of the shares subject to the option vest in 36 equal monthly installments thereafter.

F2 · derivative.underlying: 25% of the shares subject to the option vest on July 1, 2015; 1/48th of the shares subject to the option vest in 36 equal monthly installments thereafter.

SEC source: 0001415889-25-005571 · form4-02252025_110243.xml · nonDerivative · entry 30

Morrell Martha · CIK 0001855616 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 96,480

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001415889-25-005571 · form4-02252025_110243.xml · nonDerivative · entry 29

Morrell Martha · CIK 0001855616 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,480

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001415889-25-005571 · form4-02252025_110243.xml · nonDerivative · entry 28

Morrell Martha · CIK 0001855616 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,246

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001415889-25-005571 · form4-02252025_110243.xml · nonDerivative · entry 27

Morrell Martha · CIK 0001855616 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,054

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001415889-25-005571 · form4-02252025_110243.xml · nonDerivative · entry 26

Morrell Martha · CIK 0001855616 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,862

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-24-002596 · doc4.xml · nonDerivative · entry 1

Morrell Martha · CIK 0001855616 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,937

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.165, inclusive. The reporting person undertakes to provide the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.

SEC source: 0001209191-24-002322 · doc4.xml · nonDerivative · entry 2

Morrell Martha · CIK 0001855616 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 109,199

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

SEC source: 0001209191-24-002322 · doc4.xml · nonDerivative · entry 1

Morrell Martha · CIK 0001855616 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 109,200

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.06, inclusive. The reporting person undertakes to provide the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.

SEC source: 0001415889-25-005571 · form4-02252025_110243.xml · nonDerivative · entry 12

Morrell Martha · CIK 0001855616 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,076

SEC source: 0001209191-23-059946 · doc4.xml · nonDerivative · entry 2

Morrell Martha · CIK 0001855616 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 110,027

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.00 to $10.18, inclusive. The reporting person undertakes to provide the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.

SEC source: 0001209191-23-059946 · doc4.xml · nonDerivative · entry 1

Morrell Martha · CIK 0001855616 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 123,327

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

SEC source: 0001209191-23-059564 · doc4.xml · nonDerivative · entry 1

Morrell Martha · CIK 0001855616 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 123,429

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.00 to $10.27, inclusive. The reporting person undertakes to provide the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.

SEC source: 0001209191-23-057715 · doc4.xml · nonDerivative · entry 1

Morrell Martha · CIK 0001855616 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 126,159

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.05 to $8.265, inclusive. The reporting person undertakes to provide the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.

SEC source: 0001415889-25-005571 · form4-02252025_110243.xml · nonDerivative · entry 11

Morrell Martha · CIK 0001855616 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,340

SEC source: 0001415889-25-005571 · form4-02252025_110243.xml · nonDerivative · entry 10

Morrell Martha · CIK 0001855616 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 76,643

SEC source: 0001415889-25-005571 · form4-02252025_110243.xml · nonDerivative · entry 9

Morrell Martha · CIK 0001855616 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 76,874

SEC source: 0001415889-25-005571 · form4-02252025_110243.xml · nonDerivative · entry 8

Morrell Martha · CIK 0001855616 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 78,176

SEC source: 0001415889-25-005571 · form4-02252025_110243.xml · nonDerivative · entry 7

Morrell Martha · CIK 0001855616 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 78,407

SEC source: 0001415889-25-005571 · form4-02252025_110243.xml · nonDerivative · entry 6

Morrell Martha · CIK 0001855616 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 79,710

SEC source: 0001415889-25-005571 · form4-02252025_110243.xml · nonDerivative · entry 5

Morrell Martha · CIK 0001855616 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 79,941

SEC source: 0001209191-23-011946 · doc4.xml · nonDerivative · entry 1

Morrell Martha · CIK 0001855616 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 137,164

F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 25% of the RSUs vest on February 20, 2024 and the remaining RSUs vest in eight (8) equal quarterly installments thereafter.

SEC source: 0001415889-25-005571 · form4-02252025_110243.xml · nonDerivative · entry 4

Morrell Martha · CIK 0001855616 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 85,108

SEC source: 0001415889-25-005571 · form4-02252025_110243.xml · nonDerivative · entry 3

Morrell Martha · CIK 0001855616 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 85,372

SEC source: 0001209191-22-053273 · doc4.xml · derivative · entry 4

Morrell Martha · CIK 0001855616 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 384 shares

Expires 2023-03-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The shares underlying the option are fully vested.

SEC source: 0001209191-22-053273 · doc4.xml · derivative · entry 3

Morrell Martha · CIK 0001855616 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 192 shares

Expires 2022-11-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The shares underlying the option are fully vested.

SEC source: 0001209191-22-053273 · doc4.xml · nonDerivative · entry 2

Morrell Martha · CIK 0001855616 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,164

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-22-053273 · doc4.xml · nonDerivative · entry 1

Morrell Martha · CIK 0001855616 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,780

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001415889-25-005571 · form4-02252025_110243.xml · nonDerivative · entry 2

Morrell Martha · CIK 0001855616 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 85,605

SEC source: 0001415889-25-005571 · form4-02252025_110243.xml · nonDerivative · entry 1

Morrell Martha · CIK 0001855616 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 85,836

SEC source: 0001209191-22-016874 · doc4.xml · derivative · entry 2

Morrell Martha · CIK 0001855616 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 93,530

Underlying: Common Stock · 93,530 shares

Expires 2032-03-02

F2 · derivative.exercise_date: 25% of the shares subject to the option vest on March 3, 2023. The remaining shares subject to the option vest in thirty six (36) equal consecutive monthly installments thereafter. The option is early exercisable.

SEC source: 0001209191-22-016874 · doc4.xml · nonDerivative · entry 1

Morrell Martha · CIK 0001855616 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,588

F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 25% of the RSUs vest on March 3, 2023 and the remaining RSUs vest in twelve (12) equal quarterly installments thereafter.

SEC source: 0001209191-21-038996 · doc4.xml · derivative · entry 2

Morrell Martha · CIK 0001855616 · Chief Medical officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,363

Underlying: Common Stock · 16,363 shares

Expires 2031-06-03

F2 · derivative.exercise_date: 25% of the shares subject to the option vest on April 22, 2022. The remaining shares subject to the option vest in twelve (12) equal quarterly installments thereafter. The option is early exercisable.

SEC source: 0001209191-21-038996 · doc4.xml · nonDerivative · entry 1

Morrell Martha · CIK 0001855616 · Chief Medical officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,699

F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 25% of the RSUs vest on April 22, 2022 and the remaining RSUs vest in twelve (12) equal quarterly installments thereafter.

SEC source: 0001209191-21-043742 · doc4a.xml · derivative · entry 2

Morrell Martha · CIK 0001855616 · Chief Medical officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,620

Underlying: Common Stock · 16,620 shares

Expires 2031-06-03

F2 · derivative.exercise_date: 25% of the shares subject to the option vest on April 22, 2022. The remaining shares subject to the option vest in twelve (12) equal quarterly installments thereafter. The option is early exercisable.

SEC source: 0001209191-21-043742 · doc4a.xml · nonDerivative · entry 1

Morrell Martha · CIK 0001855616 · Chief Medical officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,828

F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 25% of the RSUs vest on April 22, 2022 and the remaining RSUs vest in twelve (12) equal quarterly installments thereafter.